- Home
- XERS vs HRTG Comparison
XERS vs HRTG Comparison
Compare XERS & HRTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XERS | HRTG |
|---|---|---|
| Founded | 2005 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 898.0M |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | XERS | HRTG |
|---|---|---|
| Price | $6.16 | $29.24 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | $10.83 | ★ $33.50 |
| AVG Volume (30 Days) | ★ 1.3M | 253.3K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 100.00 | ★ 214.43 |
| EPS | N/A | ★ 6.32 |
| Revenue | $49,590,000.00 | ★ $847,330,000.00 |
| Revenue This Year | $34.37 | $7.50 |
| Revenue Next Year | $22.86 | $6.74 |
| P/E Ratio | ★ N/A | $4.68 |
| Revenue Growth | ★ 142.67 | 3.71 |
| 52 Week Low | $4.26 | $16.83 |
| 52 Week High | $10.08 | $31.98 |
Technical Indicators
Market Signals| Indicator | XERS | HRTG |
|---|---|---|
| Relative Strength Index (RSI) | 53.84 | 62.29 |
| Support Level | $5.79 | $25.28 |
| Resistance Level | $6.41 | $30.57 |
| Average True Range (ATR) | 0.20 | 1.05 |
| MACD | 0.01 | 0.30 |
| Stochastic Oscillator | 57.74 | 64.18 |
Price Performance
Historical ComparisonAbout XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of endogenous hypercortisolemia in patients with Cushing's syndrome; Gvoke for the treatment of severe hypoglycemia; and Keveyis for the treatment of Primary Periodic Paralysis (PPP). Additionally, the company is advancing its Phase 3-ready pipeline product, XP-8121, a once-weekly subcutaneous injection of levothyroxine, which leverages its proprietary technology, XeriSol.
About HRTG Heritage Insurance Holdings Inc.
Heritage Insurance Holdings Inc is a regional property and casualty insurance company that offers a variety of personal and commercial insurance products. Through its subsidiaries, Heritage Property & Casualty Insurance, Narragansett Bay Insurance, and Zephyr Insurance, the company issues personal residential property insurance in various states in the United States. It also offers commercial residential insurance predominantly for its Florida properties. Heritage Insurance manages insurance underwriting, customer services, actuarial analysis, distribution, and claims processing internally. Company operates in Alabama, California, Connecticut, Delaware, Florida, Georgia, Hawaii, Maryland, Massachusetts, Mississippi, New Jersey, New York, North Carolina, Rhode Island, South Carolina.